SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455244-10-000099
Filing Date
2010-04-26
Accepted
2010-04-26 17:22:29
Documents
1
Period of Report
2010-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 51090
  Complete submission text file 0001455244-10-000099.txt   53703
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
SUPERGEN INC (Issuer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OSTERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN G7 G7
Business Address
Schonharting Florian (Reporting) CIK: 0001360509 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27628 | Film No.: 10771059

Mailing Address OSTERGADE 5, 3RD FLOOR DK-1100 DENMARK G7 G7
Business Address
Hansen Christian (Reporting) CIK: 0001360573 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27628 | Film No.: 10771060

Mailing Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 -----
Business Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 ----- 45 70 20 12 63
NB Public Equity K/S (Reporting) CIK: 0001451330 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27628 | Film No.: 10771061